Plain-English translation of NCT06723145 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether should be continued or stopped before abdominal surgery in patients who have previously had a stent placed in their heart coronary artery. About one in five people with heart stents need abdominal surgery within a few years, but doctors don't have clear evidence about the safest way to manage this medication during surgery. This study will help answer that question by comparing two approaches: keeping patients on versus stopping it for a week before surgery.
When you have a heart stent, helps prevent dangerous blood clots. However, before surgery, doctors worry that continuing the medication might increase bleeding risk. Right now, there's not enough scientific evidence to guide doctors on the best approach, so this research aims to clarify whether continuing the medication is safer overall.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either continue taking throughout your surgery or to stop taking it for 5–7 days before your procedure. Researchers will then follow you after surgery to monitor for any heart-related problems or excessive bleeding. The study involves about 1,200 patients, so you'll be part of a large effort to provide clear evidence for doctors treating patients like you in the future.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
Japan
Phase
Post-approval monitoring
Sponsor
Kyoto University
Enrollment target
~1,200 participants
Started
January 2025
Primary completion
February 2027
Age range
20 Years and older
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hiroki Shiomi, MD, PhD
Kyoto University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.